New trial
A Study to Assess Adverse Events and Change in Disease Activity With Treatment Combinations With Telisotuzumab Adizutecan in Adults Participants With Pancreatobiliary Cancers
Why it was picked newest record on or before this date
The Pancreatic Cancer Research Digest
New trials, papers and changes to existing records, compiled daily from the public registries
10 items · 0 changes to existing records
New paper
Integrated Post-Translational Modification (PTM) Proteomics Reveals Early Redox and Mitochondrial Remodeling Following Ref-1 Inhibition in Pancreatic Cancer
Why it was picked newest record on or before this date
New paper
Plectin promotes an aggressive phenotype and represses cytotoxic T cell activity in pancreatic cancer.
Why it was picked newest record on or before this date
New paper
Microbiome Disturbance, Nutritional Vulnerability, and Treatment Tolerance in Pancreatic Ductal Adenocarcinoma: Mechanistic Links and Clinical Readiness.
Why it was picked newest record on or before this date
New paper
Leukocyte telomere length and gut microbiome profiles in pancreatic ductal adenocarcinoma and at-risk conditions.
Why it was picked newest record on or before this date
Also today
New paper
Endoscopic ultrasound-guided radiofrequency ablation in the treatment of pancreatic ductal adenocarcinoma: when science tries to increases hope.
New paper
Guanylate-binding protein 2 (GBP2) drives pancreatic cancer cell proliferation by promoting cell cycle progression via the SP1/SKP2/P27 axis.
New paper
Development of a mobile high-intensity focused ultrasound platform for preclinical tumor microenvironment modulation in a pancreatic ductal adenocarcinoma mouse model.
New paper
Low-protein diet enhances antitumor immunity in pancreatic cancer through microbiota-derived UDP-galactose.
Change tracking began 4 November 2026, after this day, so only its new records are listed.
Compiled by the knowledge layer from its change log. Every headline opens the underlying record; every identifier links to its source.